Urology Devices Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	159 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19260710

Best Price Guarantee
Price	from $4,850
Length	159 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19260710

Urology Devices Market

Growth Factors of Urology Devices Market

The Urology Devices market size was valued at USD 34.06 billion in 2023, and the market is now projected to grow from USD 36.34 billion in 2024 to USD 64.33 billion by 2032, exhibiting a CAGR of 7.4% during the forecast period of 2024-2032.

In the havoc of the pandemic the market was disrupted there was a low urology devices market growth due to lower persistent volumes and delays in elective surgeries. The reallocation of healthcare assets for COVID-19 treatment, the declining number of persistent visits to clinics & claim to fame clinics, the disturbances in supply chains, and other major parameters affected the deals of cystoscopes, laser & lithotripsy, and urology adornments over the globe. However, in 2021, elective surgeries were continued as the controls forced by the governments over different nations were relaxed.

The wide array of benefits of single-use adaptable cystoscopes incorporates decreased contamination transmission and reliable quality with no requirement for the reprocessing or repairs. Moreover, the surge in mindfulness with respect to the benefits of single-use cystoscopes invigorates a few producers to extend their advancement and clinical inquire about to introduce expendable cystoscopes within the market.

The growing incidence of the kidney disorders such as unremitting kidney illnesses and kidney failure are the major variables for the expanded selection of dialysis gadgets all inclusive. Besides, an expansive persistent pool for dialysis treatment expanded dialysis item utilization, such as dialysate and hemodialysis machines. The major operating companies are presenting urology devices, subsequently impelling worldwide urology gadgets market development.

Comprehensive Analysis of Urology Devices Market

On the foundational type, the market arena is further disseminated into, endoscopes, laser & lithotripsy gadgets, dialysis gadgets, other gadgets, and accessories. The fragment type termed as endoscope is governed to grow and rule out the type portion. On the bifunctional analysis, the application of the marketplace is fragmented into urolithiasis, urethral malignancies, bladder clutters, kidney infections, and others. In the year 2023, the kidney maladies section held the biggest showcase share. The Urology devices market is majorly classified on the end-user analysis as hospitals & mobile surgical centers, dialysis centers, and others. In the year of 2023, the hospitals & mobile surgical centers fragment held the biggest market share.

The territory of North America is governed to rule out the urology devices market share with a revenue share of USD 12.87 billion in 2023 and is anticipated to proceed its dominance amid the estimate time allotment. The expanding number of patients detecting from kidney infections, the surge in patient-visits for treatment and conclusion, and the solid nearness of key showcase players within the region are expected to drive the market.

Key showcase players are entering into key organizations and collaborations. These bargains with advanced advancement providers offer help in publicizing industry specific courses of action. The affiliation with distinctive industry players is creating to meet the extending require for clean and environment-friendly operations. The key players are developing over diverse countries to accomplish around the world closeness and boost bargains wage. List of Key Companies Profiled: Stryker (U.S.), Olympus Corporation (Japan), Ambu A/S (Denmark), Coloplast A/S (Denmark), Cook Medical (U.S.), Richard Wolf GmbH (Germany), Rocamed (Monaco), Siemens Healthcare GmbH (Germany), The Boston Scientific Corporation (U.S.) and Dornier Medtech (Germany) among others.

In January 2024, the company Boston Logical Organization entered into a conclusive assention to obtain Axonics, Inc. This procurement would extend the urology portfolio of Boston Logical Organization with separated innovations to treat urinary and bowel brokenness.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 7.4% from 2024-2032

Unit Value (USD billion)

By Product Type, By Application, By End-user, and By Region

Segmentation By Product Type

Endoscopes

Cystoscopes

- Disposable

- Reusable

Ureteroscopes

- Disposable

- Reusable

Other Endoscopes

Laser & Lithotripsy Devices

Dialysis Devices

Other Devices

Accessories

By Application

Urolithiasis

Urethral Malignancies

Bladder Disorders

Kidney Diseases

Others

By End-user

Hospitals & Ambulatory Surgical Centers

Dialysis Centers

Others

By Region

North America (By Product Type, Application, End-user, and Country)

U.S.
Canada

Europe (By Product Type, Application, End-user, and Country/Sub-region)

Germany
U.K.
France
Spain
Italy
Scandinavia
Rest of Europe

Asia Pacific (By Product Type, Application, End-user, and Country/Sub-region)

China
Japan
India
Australia
Southeast Asia
Rest of Asia Pacific

Latin America (By Product Type, Application, End-user, and Country/Sub-region)

Brazil
Mexico
Rest of Latin America

Middle East & Africa (By Product Type, Application, End-user, and Country/Sub-region)

GCC
South Africa
Rest of Middle East & Africa

1. Introduction: 1.1. Market Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Key Industry Developments – Mergers, Acquisitions and Partnerships; 4.2. Technological Advancements in Urology Endoscopy; 4.3. Prevalence of Urinary Disorders, by Key Countries/Regions, 2022/2023; 4.4. New Product Launches, By Key Players; 4.5. Impact of COVID-19 on the Market
5. Global Urology Devices Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Product Type; 5.1.1. Endoscopes; 5.1.1.1. Cystoscopes; 5.1.1.1.1. Disposable; 5.1.1.1.2. Reusable; 5.1.1.2. Ureteroscopes; 5.1.1.2.1. Disposable; 5.1.1.2.2. Reusable
6. 5.1.1.3.Other Endoscopes: 6.1.; 6.1.1. Laser & Lithotripsy Devices; 6.1.2. Dialysis Devices; 6.1.3. Other Devices; 6.1.4. Accessories; 6.2. Market Analysis, Insights and Forecast – By Application; 6.2.1. Urolithiasis; 6.2.2. Urethral Malignancies; 6.2.3. Bladder Disorders; 6.2.4. Kidney Diseases; 6.2.5. Others; 6.3. Market Analysis, Insights and Forecast – By End-user; 6.3.1. Hospitals & Ambulatory Surgical Centers; 6.3.2. Dialysis Centers; 6.3.3. Others; 6.4. Market Analysis, Insights and Forecast – By Region; 6.4.1. North America; 6.4.2. Europe; 6.4.3. Asia Pacific; 6.4.4. Rest of World
7. North America Urology Devices Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Product Type; 7.1.1. Endoscopes; 7.1.1.1. Cystoscopes; 7.1.1.1.1. Disposable; 7.1.1.1.2. Reusable; 7.1.1.2. Ureteroscopes; 7.1.1.2.1. Disposable; 7.1.1.2.2. Reusable
8. 6.1.1.3.Other Endoscopes: 8.1.; 8.1.1. Laser & Lithotripsy Devices; 8.1.2. Dialysis Devices; 8.1.3. Other Devices; 8.1.4. Accessories; 8.2. Market Analysis, Insights and Forecast – By Application; 8.2.1. Urolithiasis; 8.2.2. Urethral Malignancies; 8.2.3. Bladder Disorders; 8.2.4. Kidney Diseases; 8.2.5. Others; 8.3. Market Analysis, Insights and Forecast – By End-user; 8.3.1. Hospitals & Ambulatory Surgical Centers; 8.3.2. Dialysis Centers; 8.3.3. Others; 8.4. Market Analysis, Insights and Forecast – By Country/Sub-region; 8.4.1. U.S.; 8.4.1.1. By Application; 8.4.2. Canada; 8.4.2.1. By Application
9. Europe Urology Devices Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Product Type; 9.1.1. Endoscopes; 9.1.1.1. Cystoscopes; 9.1.1.1.1. Disposable; 9.1.1.1.2. Reusable; 9.1.1.2. Ureteroscopes; 9.1.1.2.1. Disposable; 9.1.1.2.2. Reusable
10. 7.1.1.3.Other Endoscopes: 10.1.; 10.1.1. Laser & Lithotripsy Devices; 10.1.2. Dialysis Devices; 10.1.3. Other Devices; 10.1.4. Accessories; 10.2. Market Analysis, Insights and Forecast – By Application; 10.2.1. Urolithiasis; 10.2.2. Urethral Malignancies; 10.2.3. Bladder Disorders; 10.2.4. Kidney Diseases; 10.2.5. Others; 10.3. Market Analysis, Insights and Forecast – By End-user; 10.3.1. Hospitals & Ambulatory Surgical Centers; 10.3.2. Dialysis Centers; 10.3.3. Others; 10.4. Market Analysis, Insights and Forecast – By Country/Sub-region; 10.4.1. U.K.; 10.4.1.1. By Application; 10.4.2. Germany; 10.4.2.1. By Application; 10.4.3. France; 10.4.3.1. By Application; 10.4.4. Spain; 10.4.4.1. By Application; 10.4.5. Italy; 10.4.5.1. By Application; 10.4.6. Scandinavia; 10.4.6.1. By Application; 10.4.7. Rest of Europe; 10.4.7.1. By Application
11. Asia Pacific Urology Devices Market Analysis, Insights and Forecast, 2019-2032: 11.1. Market Analysis, Insights and Forecast – By Product Type; 11.1.1. Endoscopes; 11.1.1.1. Cystoscopes; 11.1.1.1.1. Disposable; 11.1.1.1.2. Reusable; 11.1.1.2. Ureteroscopes; 11.1.1.2.1. Disposable; 11.1.1.2.2. Reusable
12. 8.1.1.3.Other Endoscopes: 12.1.; 12.1.1. Laser & Lithotripsy Devices; 12.1.2. Dialysis Devices; 12.1.3. Other Devices; 12.1.4. Accessories; 12.2. Market Analysis, Insights and Forecast – By Application; 12.2.1. Urolithiasis; 12.2.2. Urethral Malignancies; 12.2.3. Bladder Disorders; 12.2.4. Kidney Diseases; 12.2.5. Others; 12.3. Market Analysis, Insights and Forecast – By End-user; 12.3.1. Hospitals & Ambulatory Surgical Centers; 12.3.2. Dialysis Centers; 12.3.3. Others; 12.4. Market Analysis, Insights and Forecast – By Country/Sub-region; 12.4.1. Japan; 12.4.1.1. By Application; 12.4.2. China; 12.4.2.1. By Application; 12.4.3. India; 12.4.3.1. By Application; 12.4.4. Australia; 12.4.4.1. By Application; 12.4.5. Southeast Asia; 12.4.5.1. By Application; 12.4.6. Rest of Asia Pacific; 12.4.6.1. By Application
13. Rest of the World Market Analysis, Insights and Forecast, 2019-2032: 13.1. Market Analysis, Insights and Forecast – By Product Type; 13.1.1. Endoscopes; 13.1.1.1. Cystoscopes; 13.1.1.1.1. Disposable; 13.1.1.1.2. Reusable; 13.1.1.2. Ureteroscopes; 13.1.1.2.1. Disposable; 13.1.1.2.2. Reusable
14. 9.1.1.3.Other Endoscopes: 14.1.; 14.1.1. Laser & Lithotripsy Devices; 14.1.2. Dialysis Devices; 14.1.3. Other Devices; 14.1.4. Accessories; 14.2. Market Analysis, Insights and Forecast – By Application; 14.2.1. Urolithiasis; 14.2.2. Urethral Malignancies; 14.2.3. Bladder Disorders; 14.2.4. Kidney Diseases; 14.2.5. Others; 14.3. Market Analysis, Insights and Forecast – By End-user; 14.3.1. Hospitals & Ambulatory Surgical Centers; 14.3.2. Dialysis Centers; 14.3.3. Others
15. Competitive Analysis: 15.1. Global Market Share Analysis (2023); 15.2. Company Profiles; 15.2.1. Boston Scientific Corporation; 15.2.1.1. Overview; 15.2.1.2. Products; 15.2.1.3. SWOT Analysis; 15.2.1.4. Recent Developments; 15.2.1.5. Strategies; 15.2.1.6. Financials (Based on Availability); 15.2.2. Coloplast A/S; 15.2.2.1. Overview; 15.2.2.2. Products; 15.2.2.3. SWOT Analysis; 15.2.2.4. Recent Developments; 15.2.2.5. Strategies; 15.2.2.6. Financials (Based on Availability); 15.2.3. Ethicon, Inc. (Johnson & Johnson Services, Inc.); 15.2.3.1. Overview; 15.2.3.2. Products; 15.2.3.3. SWOT Analysis; 15.2.3.4. Recent Developments; 15.2.3.5. Strategies; 15.2.3.6. Financials (Based on Availability); 15.2.4. Ambu A/S; 15.2.4.1. Overview; 15.2.4.2. Products; 15.2.4.3. SWOT Analysis; 15.2.4.4. Recent Developments; 15.2.4.5. Strategies; 15.2.4.6. Financials (Based on Availability); 15.2.5. KARL STORZ SE & Co. KG; 15.2.5.1. Overview; 15.2.5.2. Products; 15.2.5.3. SWOT Analysis; 15.2.5.4. Recent Developments; 15.2.5.5. Strategies; 15.2.5.6. Financials (Based on Availability); 15.2.6. Olympus Corporation; 15.2.6.1. Overview; 15.2.6.2. Products; 15.2.6.3. SWOT Analysis; 15.2.6.4. Recent Developments; 15.2.6.5. Strategies; 15.2.6.6. Financials (Based on Availability); 15.2.7. Richard Wolf GmbH; 15.2.7.1. Overview; 15.2.7.2. Products; 15.2.7.3. SWOT Analysis; 15.2.7.4. Recent Developments; 15.2.7.5. Strategies; 15.2.7.6. Financials (Based on Availability); 15.2.8. Siemens Healthcare GmbH; 15.2.8.1. Overview; 15.2.8.2. Products; 15.2.8.3. SWOT Analysis; 15.2.8.4. Recent Developments; 15.2.8.5. Strategies; 15.2.8.6. Financials (Based on Availability); 15.2.9. Stryker; 15.2.9.1. Overview; 15.2.9.2. Products; 15.2.9.3. SWOT Analysis; 15.2.9.4. Recent Developments; 15.2.9.5. Strategies; 15.2.9.6. Financials (Based on Availability); 15.2.10. Cook Medical; 15.2.10.1. Overview; 15.2.10.2. Products; 15.2.10.3. SWOT Analysis; 15.2.10.4. Recent Developments; 15.2.10.5. Strategies; 15.2.10.6. Financials (Based on Availability); 15.2.11. Dornier Medtech; 15.2.11.1. Overview; 15.2.11.2. Products; 15.2.11.3. SWOT Analysis; 15.2.11.4. Recent Developments; 15.2.11.5. Strategies; 15.2.11.6. Financials (Based on Availability); 15.2.12. Rocamed; 15.2.12.1. Overview; 15.2.12.2. Products; 15.2.12.3. SWOT Analysis; 15.2.12.4. Recent Developments; 15.2.12.5. Strategies; 15.2.12.6. Financials (Based on Availability)